CClinicalTrials.gg
CompletedNCT06498583Updated Apr 22, 2026

Effect of Ultrasound-guided Erector Spinae Plane Block on Postoperative Pain and Sleep Quality of Infants With Congenital Pulmonary Cystic Disease After Thoracoscopic Surgery

An interventional study of Ropivacaine and erector spinae plane block in Cystic Adenomatoid Malformation of Lung, Congenital, Bronchopulmonary Sequestration and Bronchogenic Cyst, sponsored by Lei Xiaoming. Completed at 1 site in China. Open to participants aged 1 Month to 12 Months. Per ClinicalTrials.gov, last updated 2026-04-22.

Sponsored by Lei Xiaoming · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Jan 2024, registered Jun 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
68
Allocation
Randomized
Ages
1 Month to 12 Months
Sex
All
01

Study summary

This study intends to evaluate the effect of erector spinae plane block on postoperative analgesia and sleep quality in infants with congenital cystic pulmonary disease after thoracoscopic surgery, and provides reference for perioperative pain treatment in children.

Read the detailed description

Severe pain may occur after pediatric thoracic surgery, such as skin incision, rib traction, drainage tube placement, or intercostal nerve dysfunction caused by suture. Pain may cause weakened coughing power to clear secretions, decreased functional residual capacity, leading to pulmonary complications such as atelectasis and pneumonia, and postoperative acute pain develops into chronic pain. It has been reported that postoperative sleep disorders are associated with increased pain scores, which are very unfavorable for postoperative rehabilitation of pediatric patients. In clinical practice, because infants cannot accurately describe pain, their postoperative pain management may not be sufficient and has not received enough attention. But, some studies have shown that infants may feel more severe pain than adults, and the pain has a more obvious and lasting effect on infants and young children than on adults.

Congenital pulmonary cystic disease is a rare congenital pulmonary developmental abnormality in clinic. It can't heal itself and is easy to cause various complications. Once diagnosed, surgical treatment should be considered immediately.

In the past experience, thoracic epidural block and thoracic paravertebral nerve block are commonly used for postoperative analgesia in thoracic surgery, but they have taboos such as abnormal coagulation function, high technical requirements and potential risks of serious complications.

Since the erector spinae plane block (ESPB) was first reported and successfully implemented in 2016, because it is far away from the neural axis, major vascular structures, pleura and other structures, with a lower possibility of complications, simpler operation and higher safety, it has been widely used in perioperative analgesia and acute and chronic pain in cardiothoracic surgery, breast surgery, abdominal surgery, spinal surgery, etc. However, the reports on pediatric patients are still mainly case reports, and there is a lack of large-sample randomized controlled clinical trials. Therefore, this study intends to perform erector spinae plane block under ultrasound guidance to observe the effect on postoperative analgesia and sleep quality in pediatric thoracoscopic surgery.

02

Conditions studied

  • Cystic Adenomatoid Malformation of Lung, Congenital
  • Bronchopulmonary Sequestration
  • Bronchogenic Cyst
03

In context

Lead sponsor

This is the only study on the registry with Lei Xiaoming as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Month to 12 Months
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • American Society of Anesthesiologists (ASA) status I-II
  • age 1 month - 12 mouths old
  • preoperative diagnosis was congenital cystic lung disease
  • thoracoscopic lung lesion resection(lung lobectomy or segmentectomy)

Exclusion criteria

Exclusion Criteria:

  • patient with a history of allergy to amide local anesthetics
  • family members refused to participate in the study.
  • combined congenital heart disease
  • patient with skin damage or infection at the proposed puncture site
  • patients with scoliosis
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
68 participants (actual)

Study arms

  • Experimental
    E group

    Drug: Ropivacaine · Procedure: erector spinae plane block

  • Experimental
    P group

    Drug: Ropivacaine · Procedure: Incision infiltration of local anesthesia

Interventions

  • DrugRopivacaine

    0.25 % ropivacaine ( 0.5ml / kg )

  • Procedureerector spinae plane block

    After the operation, unilateral erector spinae plane block was performed at the T5 level under ultrasound guidance.

  • ProcedureIncision infiltration of local anesthesia

    After the operation, Incision infiltration of local anesthesia is performed around the surgical incisions.

06

What researchers measure

Primary outcomes

  1. postoperative FLACC score

    Time frame: 2, 4, 6, 12, 24, 48 hours after operation

Secondary outcomes

  1. Postoperative sleep quality score

    The Pittsburgh Sleep Quality Index was used to evaluate the sleep quality of children 7 days after surgery.

    Time frame: 1, 2, 3, 4, 5, 6, 7 days after operation

  2. Number of participants with emergence agitation as assessed by PAED

    The Pediatric Anesthesia Emergence Delirium (PAED) was used to evaluate emergence agitation after extubation in post-anesthesia care unit.

    Time frame: from extubation to the child is sent back to the ward, an average of 40 minutes

  3. the amount of postoperative rescue analgesia ( with a FLACC score of >4)

    ibuprofen (5-10mg/kg) was intravenously administered as rescue analgesia.

    Time frame: 2, 4, 6, 12, 24, 48 hours after operation

07

Study locations

1 site
  • Second Affiliated Hospital of Xi 'an Jiaotong University
    Xi’an, Shanxi 710004, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06498583
Lead sponsor
Lei Xiaoming
Responsible party
Lei Xiaoming (chief physician, Xibei Hospital) — Sponsor-investigator
First posted
Jul 12, 2024
Start date
Jan 9, 2024
Primary completion
Feb 28, 2025
Completion
Mar 3, 2025
Last update
Apr 22, 2026

Study contacts

Xiaoming Lei, chief physician
study chair · Second Affiliated Hospital of Xi 'an Jiaotong University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion